About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale

February 25, 2015

Click here to read more

Post navigation

Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer

Appendix 4E Preliminary Final Financial Report

Related Posts

Quarterly Activities Report and 4C to 31 March 2022

April 29, 2022April 29, 2022

Quarterly Shareholder Update

July 1, 2015

Expansion of clinical program with the Lambert Initiative

February 22, 2023February 22, 2023

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.